IP Library Granted Patent US 6,882,166
Granted Patent B2
US 6,882,166 · App. 10/190,246 · Granted Apr 19, 2005

System and method for measuring the validity of a bioelectric impedance measurement in the presence of interference

Assignee: Aspect Medical Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,882,166
App. No.
10/190,246
Granted
Apr 19, 2005
Kind
B2
Abstract

A method for measuring bioelectric impedance in real time, in the presence of interference and noise is disclosed. A small electric current is injected into a biopotential electrode system, and then the measurement is tested for contamination by electrical interference or other noise sources.

Claims (9)

1. A method for measuring bioelectric impedance in a biopotential measurement system including at least two electrodes, said method comprising the steps of:

measuring bioelectric impedance by measuring a voltage at the frequency of an impedance signal

estimating noise voltage by measuring a voltage at a discrete frequency near the frequency of said impedance signal;

computing an impedance signal to noise ratio from same impedance voltage measured at the frequency of the impedance signal and said estimated noise voltage; and

determining the validity of the bioelectric impedance measurement by comparing said impedance signal to noise ratio against an impedance signal to noise ratio threshold value.

2. The method for measuring bioelectric impedance of claim 1 wherein said noise voltage of the bioelectric impedance measurement is estimated by measuring voltages at a number of discrete frequencies in a band near the frequency of the impedance signal, aggregating said voltages at each of said discrete frequencies and using an aggregated voltage value as an estimate of said noise voltage.

3. The method for measuring bioelectric impedance of claim 1 further comprising the step of enabling said system for measuring biopotential impedance if a prior measured bioelectric impedance does not exceed said impedance signal to noise ratio threshold value.

4. The method for measuring bioelectric impedance of claim 1 further comprising the step of enabling said system for measuring biopotential impedance if a prior measured bioelectric impedance exceeds said signal to noise impedance threshold and the measured impedance signal to noise ratio does not exceed the signal to noise ratio threshold.

5. The method for measuring bioelectric impedance of claim 1 further comprising the step of disabling said system for measuring biopotential impedance if a prior measured bioelectric impedance exceeds the impedance threshold and the measured impedance signal to noise ratio exceeds the signal to noise ratio threshold.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2012
From: NELLCOR PURITAN BENNETT LLC
To: COVIDIEN LP
Reel/Frame 029431/0390 →
MERGER Recorded Jan 11, 2010
From: ASPECT MEDICAL SYSTEMS, INC.
To: ASPECT MEDICAL SYSTEMS, LLC
Reel/Frame 023758/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2010
From: ASPECT MEDICAL SYSTEMS, LLC
To: NELLCOR PURITAN BENNETT LLC
Reel/Frame 023758/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2002
From: SHAMBROOM, JOHN R.; SMITH, CHARLES P.
To: ASPECT MEDICAL SYSTEMS, INC.
Reel/Frame 013072/0633 →
Continuity (2)
Provisional Application 6030353100 · Jul 6, 2001
Related Publication 20030006782A1 · Jan 9, 2003